Why the deafening silence? Suggests to me no progress on most fronts. Hopefully I'm wrong.
Wouldnt one of Oz's other cancer R&D companies contemplate an all scrip offer for SBP. One of ACL,CXS,BNO,CIR,PEP could be interested. At least this would provide shareholders ongoing exposure to upside in coramsine's development. What we don't want is some private offshore player to effectively take control for a pittance leaving shareholders minimal participation in the upside.
SBP Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held
